March 2018 – US Inventor

Controversy Over Restasis Patents is Misplaced
Controversy Over Restasis Patents is Misplaced

Controversy Over Restasis Patents is Misplaced

CONTROVERSY OVER RESTASIS PATENTS IS MISPLACED (This article first appeared on IPWatchDog) In his 2018 State of the Union speech, President Trump placed reducing the price of prescription drugs at the top of his agenda. How can he do this without harming the profit incentive that drive R&D for innovative treatments and cures? The President

The U.S. Patent System, not China’s IP Policies, is the Reason Behind America’s Decline in Global Competitiveness
The U.S. Patent System, not China’s IP Policies, is the Reason Behind America’s Decline in Global Competitiveness

The U.S. Patent System, not China’s IP Policies, is the Reason Behind America’s Decline in Global Competitiveness

THE U.S. PATENT SYSTEM, NOT CHINA’S IP POLICIES, IS THE REASON BEHIND AMERICA’S DECLINE IN GLOBAL COMPETITIVENESS Several months ago, the Trump Administration launched an investigation into Chinese trade policies that are responsible for expropriating American intellectual property (patents, trademarks, copyrights). This investigation is premised upon Section 301 of the Trade Act of 1974